Aortic Stenosis

  • Marie-Annick Clavel
  • Nancy Côté
  • Philippe PibarotEmail author


Calcific aortic stenosis (AS) is a slowly progressive disease that is characterized by fibro-calcific remodeling and stiffening of valve leaflets, which cause progressive obstruction of LV outflow. AS is the second most frequent cardiovascular disease after coronary artery disease and hypertension with a prevalence of 0.4% in the general population and 1.7% in the population over 65 years old. Congenital abnormality (bicuspid valve) and older age are the most important risk factors for AS. The pathobiology of AS is complex and involves genetic factors, lipoprotein deposition and oxidation, chronic inflammation, osteoblastic transition of valvular interstitial cells, apoptosis, and active leaflet calcification. Until now, no pharmacotherapy has proven to be effective in reducing the progression of AS. Promising therapeutic targets include Lipoprotein (a), renin-angiotensin system, and Palmdelphin. For now, aortic valve replacement (AVR) remains the sole effective option for the treatment of severe AS. AVR is indicated in presence of: (i) severe AS and (ii) symptoms and/or LV systolic dysfunction. The grading of AS severity and staging of associated cardiac damage are primarily based on Doppler-echocardiography but other imaging modalities such as multi-detector computed tomography that may provide important complementary information, particularly in patients with low-gradient AS. The introduction of transcatheter AVR in the past decade has been a transformative innovation for patients at extreme, high, or intermediate surgical risk and this new technology may extend to low risk patients in the near future.


Aortic stenosis Aortic valve Heart valve disease Doppler-echocardiography Computed tomography Heart valve prosthesis Transcatheter valve therapy 



Aortic stenosis


Aortic valve area


Aortic valve replacement


Cardiac magnetic resonance


Dobutamine stress echocardiography


LV ejection fraction


Multi-detector computed tomography


Surgical aortic valve replacement


Transcatheter aortic valve implantation



Dr. Pibarot has Core Lab contracts with Edwards Lifesciences, for which he receives no direct compensation; and is a speaker for St. Jude Medical. The other authors have no disclosure. Dr. Clavel has Core Lab contracts with Edwards Lifesciences, for which she receives no direct compensation; and research grant with Medtronic.


  1. 1.
    Lindman BR, Clavel MA, Mathieu P, Iung B, Lancellotti P, Otto CM, Pibarot P. Calcific aortic stenosis. Nat Rev Dis Primers. 2016;2:16006.PubMedPubMedCentralCrossRefGoogle Scholar
  2. 2.
    Roberts WC, Ko JM, Filardo G, Henry AC, Hebeler RF Jr, Cheung EH, Matter GJ, Hamman BL. Valve structure and survival in sexagenarians having aortic valve replacement for aortic stenosis (+/−aortic regurgitation) with versus without coronary artery bypass grafting at a single us medical center (1993 to 2005). Am J Cardiol. 2007;100:1286–92.PubMedCrossRefGoogle Scholar
  3. 3.
    Michelena HI, Prakash SK, Della Corte A, Bissell M, Anavekar N, Mathieu P, Bossé Y, Limongelli G, Bossone E, Windrow Benson D, Lancellotti P, Isselbacher EM, Enriquez-Sarano M, Sundt TM III, Pibarot P, Evangelista A, Milewicz DM, Body SC. Bicuspid aortic valve: identifying knowledge gaps and rising to the challenge from the International Bicuspid Aortic Valve Consortium (BAVCon). Circulation. 2014;129:2691–704.PubMedPubMedCentralCrossRefGoogle Scholar
  4. 4.
    Coffey S, Cox B, Williams MJ. The prevalence, incidence, progression, and risks of aortic valve sclerosis: a systematic review and meta-analysis. J Am Coll Cardiol. 2014;63:2852–61.PubMedCrossRefGoogle Scholar
  5. 5.
    Nkomo VT, Gardin JM, Skelton TN, Gottdiener JS, Scott CG, Enriquez-Sarano M. Burden of valvular heart diseases: a population-based study. Lancet. 2006;368:1005–11.PubMedCrossRefGoogle Scholar
  6. 6.
    Osnabrugge RL, Mylotte D, Head SJ, Van Mieghem NM, Nkomo VT, LeReun CM, Bogers AJ, Piazza N, Kappetein AP. Aortic stenosis in the elderly: disease prevalence and number of candidates for transcatheter aortic valve replacement: a meta-analysis and modeling study. J Am Coll Cardiol. 2013;62:1002–12.PubMedCrossRefGoogle Scholar
  7. 7.
    Andell P, Li X, Martinsson A, Andersson C, Stagmo M, Zöller B, Sundquist K, Smith JG. Epidemiology of valvular heart disease in a Swedish nationwide hospital-based register study. Heart. 2017;103:1696–703.PubMedPubMedCentralCrossRefGoogle Scholar
  8. 8.
    Eveborn GW, Schirmer H, Heggelund G, Lunde P, Rasmussen K. The evolving epidemiology of valvular aortic stenosis. The Tromso study. Heart. 2013;99:396–400.PubMedCrossRefGoogle Scholar
  9. 9.
    Iung B, Baron G, Butchart EG, Delahaye F, Gohlke-Barwolf C, Levang OW, Tornos P, Vanoverschelde J-L, Vermeer F, Boersma E, Ravaud P, Vahanian A. A prospective survey of patients with valvular heart disease in Europe: the Euro Heart Survey on valvular heart disease. Eur Heart J. 2003;24:1231–43.CrossRefGoogle Scholar
  10. 10.
    Sliwa K, Carrington M, Mayosi BM, Zigiriadis E, Mvungi R, Stewart S. Incidence and characteristics of newly diagnosed rheumatic heart disease in urban African adults: insights from the heart of Soweto study. Eur Heart J. 2010;31:719–27.PubMedCrossRefGoogle Scholar
  11. 11.
    Katz R, Wong ND, Kronmal R, Takasu J, Shavelle DM, Probstfield JL, Bertoni AG, Budoff MJ, O'Brien KD. Features of the metabolic syndrome and diabetes mellitus as predictors of aortic valve calcification in the multi-ethnic study of atherosclerosis. Circulation. 2006;113:2113–9.PubMedCrossRefGoogle Scholar
  12. 12.
    Tastet L, Capoulade R, Clavel MA, Larose É, Shen M, Dahou A, Arsenault M, Mathieu P, Bédard É, Dumesnil JG, Tremblay A, Bossé Y, Després JP, Pibarot P. Systolic hypertension and progression of aortic valve calcification in patients with aortic stenosis: results from the PROGRESSA study. Eur Heart J Cardiovasc Imaging. 2017;18:70–8.PubMedCrossRefGoogle Scholar
  13. 13.
    Larsson SC, Wolk A, Hakansson N, Back M. Overall and abdominal obesity and incident aortic valve stenosis: two prospective cohort studies. Eur Heart J. 2017;38:2192–7.PubMedPubMedCentralCrossRefGoogle Scholar
  14. 14.
    Thanassoulis G, Campbell CY, Owens DS, Smith JG, Smith AV, Peloso GM, Kerr KF, Pechlivanis S, Budoff MJ, Harris TB, Malhotra R, O’Brien KD, Kamstrup PR, Nordestgaard BG, Tybjaerg-Hansen A, Allison MA, Aspelund T, Criqui MH, Heckbert SR, Hwang SJ, Liu Y, Sjogren M, van der Pals J, Kalsch H, Muhleisen TW, Nothen MM, Cupples LA, Caslake M, Di Angelantonio E, Danesh J, Rotter JI, Sigurdsson S, Wong Q, Erbel R, Kathiresan S, Melander O, Gudnason V, O’Donnell CJ, Post WS. Genetic associations with valvular calcification and aortic stenosis. N Engl J Med. 2013;368:503–12.PubMedPubMedCentralCrossRefGoogle Scholar
  15. 15.
    Smith JG, Luk K, Schulz CA, Engert JC, Do R, Hindy G, Rukh G, Dufresne L, Almgren P, Owens DS, Harris TB, Peloso GM, Kerr KF, Wong Q, Smith AV, Budoff MJ, Rotter JI, Cupples LA, Rich S, Kathiresan S, Orho-Melander M, Gudnason V, O’Donnell CJ, Post WS, Thanassoulis G. Association of low-density lipoprotein cholesterol-related genetic variants with aortic valve calcium and incident aortic stenosis. JAMA. 2014;312:1764–71.PubMedPubMedCentralCrossRefGoogle Scholar
  16. 16.
    Capoulade R, Clavel MA, Dumesnil JG, Chan KL, Teo KK, Tam JW, Côté N, Mathieu P, Després JP, Pibarot P. Impact of metabolic syndrome on progression of aortic stenosis: influence of age and statin therapy. J Am Coll Cardiol. 2012;60:216–23.PubMedCrossRefGoogle Scholar
  17. 17.
    Capoulade R, Mahmut A, Tastet L, Arsenault M, Bédard E, Dumesnil JG, Després JP, Larose É, Arsenault BJ, Bossé Y, Mathieu P, Pibarot P. Impact of plasma Lp-PLA2 activity on the progression of aortic stenosis: the PROGRESSA study. J Am Coll Cardiol Img. 2015;8:26–33.CrossRefGoogle Scholar
  18. 18.
    Capoulade R, Chan KL, Yeang C, Mathieu P, Bossé Y, Dumesnil JG, Tam JW, Teo KK, Mahmut A, Yang X, Witztum JL, Arsenault BJ, Després JP, Pibarot P, Tsimikas S. Oxidized phospholipids, lipoprotein(a), and progression of calcific aortic valve stenosis. J Am Coll Cardiol. 2015;66:1236–46.PubMedCrossRefGoogle Scholar
  19. 19.
    Probst V, Le SS, Legendre A, Jousseaume V, Jaafar P, Nguyen JM, Chaventre A, Le MH, Schott JJ. Familial aggregation of calcific aortic valve stenosis in the western part of France. Circulation. 2006;113:856–60.PubMedCrossRefGoogle Scholar
  20. 20.
    Cripe L, Andelfinger G, Martin LJ, Shooner K, Benson DW. Bicuspid aortic valve is heritable. J Am Coll Cardiol. 2004;44:138–43.PubMedPubMedCentralCrossRefGoogle Scholar
  21. 21.
    Bossé Y, Mathieu P, Pibarot P. Genomics: the next step to elucidate the etiology of calcific aortic valve stenosis. J Am Coll Cardiol. 2008;51:1327–36.PubMedCrossRefGoogle Scholar
  22. 22.
    Garg V, Muth AN, Ransom JF, Schluterman MK, Barnes R, King IN, Grossfeld PD, Srivastava D. Mutations in NOTCH1 cause aortic valve disease. Nature. 2005;437:270–4.PubMedPubMedCentralCrossRefGoogle Scholar
  23. 23.
    Laforest B, Andelfinger G, Nemer M. Loss of Gata5 in mice leads to bicuspid aortic valve. J Clin Invest. 2011;121:2876–87.PubMedPubMedCentralCrossRefGoogle Scholar
  24. 24.
    Kamstrup PR, Tybjaerg-Hansen A, Nordestgaard BG. Elevated lipoprotein(a) and risk of aortic valve stenosis in the general population. J Am Coll Cardiol. 2014;63:470–7.PubMedCrossRefGoogle Scholar
  25. 25.
    Arsenault BJ, Boekholdt SM, Dubé MP, Rhéaume É, Wareham NJ, Khaw KT, Sandhu MS, Tardif JC. Lipoprotein(a) levels, genotype and incident aortic valve stenosis: a prospective mendelian randomization study and replication in a case-control cohort. Circ Cardiovasc Genet. 2014;7:304–10.PubMedCrossRefGoogle Scholar
  26. 26.
    Que X, Hung MY, Yeang C, Gonen A, Prohaska TA, Sun X, Diehl C, Määttä A, Gaddis DE, Bowden K, Pattison J, MacDonald JG, Ylä-Herttuala S, Mellon PL, Hedrick CC, Ley K, Miller YI, Glass CK, Peterson KL, Binder CJ, Tsimikas S, Witztum JL. Oxidized phospholipids are proinflammatory and proatherogenic in hypercholesterolaemic mice. Nature. 2018;558:301–6.PubMedPubMedCentralCrossRefGoogle Scholar
  27. 27.
    Cowell SJ, Newby DE, Prescott RJ, Bloomfield P, Reid J, Northridge DB, Boon NA. A randomized trial of intensive lipid-lowering therapy in calcific aortic stenosis. N Engl J Med. 2005;352:2389–97.PubMedCrossRefGoogle Scholar
  28. 28.
    Chan KL, Teo K, Dumesnil JG, Ni A, Tam J. Effect of lipid lowering with rosuvastatin on progression of aortic stenosis. Results of the aortic stenosis progression observation: measuring effects of rosuvastatin (astronomer) trial. Circulation. 2010;121:306–14.PubMedCrossRefGoogle Scholar
  29. 29.
    Rossebo AB, Pedersen TR, Boman K, Brudi P, Chambers JB, Egstrup K, Gerdts E, Gohlke-Barwolf C, Holme I, Kesaniemi YA, Malbecq W, Nienaber CA, Ray S, Skjaerpe T, Wachtell K, Willenheimer R. Intensive lipid lowering with simvastatin and ezetimibe in aortic stenosis. N Engl J Med. 2008;359:1343–56.PubMedCrossRefGoogle Scholar
  30. 30.
    Helgadottir A, Thorleifsson G, Gretarsdottir S, Stefansson OA, Tragante V, Thorolfsdottir RB, Jonsdottir I, Bjornsson T, Steinthorsdottir V, Verweij N, Nielsen JB, Zhou W, Folkersen L, Martinsson A, Heydarpour M, Prakash S, Oskarsson G, Gudbjartsson T, Geirsson A, Olafsson I, Sigurdsson EL, Almgren P, Melander O, Franco-Cereceda A, Hamsten A, Fritsche F, Lin M, Yang B, Hornsby W, Guo D, Brummett CM, Abecasis G, Mathis M, Milewicz D, Body SC, Eriksson P, Willer CJ, Hveem K, Newton-Cheh C, Smith JG, Danielsen R, Thorgeirsson G, Thorsteinsdottir U, Gudbjartsson DF, Holm H, Stefansson K. Genome-wide analysis yields new loci associating with aortic valve stenosis. Nat Commun. 2018;9:987.PubMedPubMedCentralCrossRefGoogle Scholar
  31. 31.
    Thériault S, Gaudreault N, Lamontagne M, Rosa M, Boulanger MC, Messika-Zeitoun D, Clavel MA, Capoulade R, Dagenais F, Pibarot P, Mathieu P, Bossé Y. A transcriptome-wide association study identifies palmd as a susceptibility gene for calcific aortic valve stenosis. Nat Commun. 2018;9:998.CrossRefGoogle Scholar
  32. 32.
    Rajappan K, Rimoldi O, Camici PG, Pennell DJ, Sheridan DJ. Factors influencing coronary microcirculatory function in patients with aortic stenosis after aortic valve replacement. Circulation. 2002;106:II-640.CrossRefGoogle Scholar
  33. 33.
    Rajappan K, Rimoldi OE, Camici PG, Bellenger NG, Pennell DJ, Sheridan DJ. Functional changes in coronary microcirculation after valve replacement in patients with aortic stenosis. Circulation. 2003;107:3170–5.PubMedCrossRefGoogle Scholar
  34. 34.
    Garcia D, Camici PG, Durand LG, Rajappan K, Gaillard E, Rimoldi OE, Pibarot P. Impairment of coronary flow reserve in aortic stenosis. J Appl Physiol. 2009;106:113–21.PubMedPubMedCentralCrossRefGoogle Scholar
  35. 35.
    Chin CW, Everett RJ, Kwiecinski J, Vesey AT, Yeung E, Esson G, Jenkins W, Koo M, Mirsadraee S, White AC, Japp AG, Prasad SK, Semple S, Newby DE, Dweck MR. Myocardial fibrosis and cardiac decompensation in aortic stenosis. JACC Cardiovasc Imaging. 2017;10:1320–33.PubMedPubMedCentralCrossRefGoogle Scholar
  36. 36.
    Julius BK, Spillmann M, Vassalli G, Villari B, Eberli FR, Hess OM. Angina pectoris in patients with aortic stenosis and normal coronary arteries. Mechanisms and pathophysiological concepts. Circulation. 1997;95:892–8.PubMedCrossRefGoogle Scholar
  37. 37.
    Dumesnil JG, Shoucri RM, Laurenceau JL, Turcot J. A mathematical model of the dynamic geometry of the intact left ventricle and its application to clinical data. Circulation. 1979;59:1024–34.PubMedCrossRefGoogle Scholar
  38. 38.
    Lancellotti P, Donal E, Magne J, Moonen M, O’Connor K, Daubert JC, Piérard LA. Risk stratification in asymptomatic moderate to severe aortic stenosis: the importance of the valvular, arterial and ventricular interplay. Heart. 2010;96:1364–71.PubMedCrossRefGoogle Scholar
  39. 39.
    Kusunose K, Goodman A, Parikh R, Barr T, Agarwal S, Popovic ZB, Grimm RA, Griffin BP, Desai MY. Incremental prognostic value of left ventricular global longitudinal strain in patients with aortic stenosis and preserved ejection fraction. Circ Cardiovasc Imaging. 2014;7:938–45.PubMedCrossRefGoogle Scholar
  40. 40.
    Baumgartner H, Hung J, Bermejo J, Chambers JB, Edvardsen T, Goldstein S, Lancellotti P, LeFevre M, Miller F Jr, Otto CM. Recommendations on the echocardiographic assessment of aortic valve stenosis: a focused update from the European Association of Cardiovascular Imaging and the American Society of Echocardiography. J Am Soc Echocardiogr. 2017;30:372–92.PubMedCrossRefGoogle Scholar
  41. 41.
    Baumgartner H, Falk V, Bax JJ, De Bonis M, Hamm C, Holm PJ, Iung B, Lancellotti P, Lansac E, Muñoz DR, Rosenhek R, Sjögren J, Tornos Mas P, Vahanian A, Walther T, Wendler O, Windecker S, Zamorano JL. 2017 ESC/EACTS guidelines for the management of valvular heart disease: the task force for the management of valvular heart disease of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS). Eur Heart J. 2017;38:2739–91.PubMedPubMedCentralCrossRefGoogle Scholar
  42. 42.
    Nishimura RA, Otto CM, Bonow RO, Carabello BA, Erwin JP 3rd, Fleisher LA, Jneid H, Mack MJ, McLeod CJ, O’Gara PT, Rigolin VH, Sundt TM 3rd, Thompson A. 2017 AHA/ACC focused update of the 2014 AHA/ACC guideline for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. J Am Coll Cardiol. 2017;70:252–89.PubMedPubMedCentralCrossRefGoogle Scholar
  43. 43.
    Owens DS, Budoff MJ, Katz R, Takasu J, Shavelle DM, Carr JJ, Heckbert SR, Otto CM, Probstfield JL, Kronmal RA, O’Brien KD. Aortic valve calcium independently predicts coronary and cardiovascular events in a primary prevention population. J Am Coll Cardiol. 2012;5:619–25.CrossRefGoogle Scholar
  44. 44.
    Thaden JJ, Nkomo VT, Lee KJ, Oh JK. Doppler imaging in aortic stenosis: the importance of the nonapical imaging windows to determine severity in a contemporary cohort. J Am Soc Echocardiogr. 2015;28:780–5.PubMedCrossRefGoogle Scholar
  45. 45.
    Garcia D, Pibarot P, Dumesnil JG, Sakr F, Durand LG. Assessment of aortic valve stenosis severity: a new index based on the energy loss concept. Circulation. 2000;101:765–71.PubMedCrossRefGoogle Scholar
  46. 46.
    Bahlmann E, Gerdts E, Cramariuc D, Gohlke-Baerwolf C, Nienaber CA, Wachtell K, Seifert R, Chambers JB, Kuck KH, Ray S. Prognostic value of energy loss index in asymptomatic aortic stenosis. Circulation. 2013;127:1149–56.PubMedCrossRefGoogle Scholar
  47. 47.
    Lancellotti P, Magne J, Dulgheru R, Clavel MA, Donal E, Vannan MA, Chambers J, Rosenhek R, Habib G, Lloyd G, Nistri S, Garbi M, Marchetta S, Fattouch K, Coisne A, Montaigne D, Modine T, Davin L, Gach O, Radermecker M, Liu S, Gillam L, Rossi A, Galli E, Ilardi F, Tastet L, Capoulade R, Zilberszac R, Vollema EM, Delgado V, Cosyns B, Lafitte S, Bernard A, Pierard LA, Bax JJ, Pibarot P, Oury C. Outcomes of patients with asymptomatic aortic stenosis followed up in heart valve clinics. JAMA Cardiol. 2018;3(11):1060–8.PubMedPubMedCentralCrossRefGoogle Scholar
  48. 48.
    Minners J, Allgeier M, Gohlke-Baerwolf C, Kienzle RP, Neumann FJ, Jander N. Inconsistent grading of aortic valve stenosis by current guidelines: haemodynamic studies in patients with apparently normal left ventricular function. Heart. 2010;96:1463–8.PubMedCrossRefGoogle Scholar
  49. 49.
    Côté N, Simard L, Zenses AS, Tastet L, Shen M, Clisson M, Clavel MA. Impact of vascular hemodynamics on aortic stenosis evaluation: new insights into the pathophysiology of normal flow-small aortic valve area-low gradient pattern. J Am Heart Assoc. 2017;6(7)Google Scholar
  50. 50.
    Clavel MA, Guzzetti E, Annabi MS, Salaun E, Ong G, Pibarot P. Normal-flow low-gradient severe aortic stenosis: myth or reality ? Struct Heart. 2018;2:180–7.CrossRefGoogle Scholar
  51. 51.
    Clavel MA, Burwash IG, Mundigler G, Dumesnil JG, Baumgartner H, Bergler-Klein J, Sénéchal M, Mathieu P, Couture C, Beanlands R, Pibarot P. Validation of conventional and simplified methods to calculate projected valve area at normal flow rate in patients with low flow, low gradient aortic stenosis: the multicenter topas (true or pseudo severe aortic stenosis) study. J Am Soc Echocardiogr. 2010;23:380–6.PubMedCrossRefGoogle Scholar
  52. 52.
    Annabi M, Salaun E, Cosyns B, Lancellotti P, Pibarot P. Multimodality imaging assessment of prosthetic aortic valve. In: Fattouch K, Lancellotti P, Vannan M, Speziale G, editors. Advances in treatments for aortic valve and root diseases. Basel: Springer; 2018. p. 95–123.CrossRefGoogle Scholar
  53. 53.
    Tribouilloy C, Levy F, Rusinaru D, Gueret P, Petit-Eisenmann H, Baleynaud S, Jobic Y, Adams C, Lelong B, Pasquet A, Chauvel C, Metz D, Quere JP, Monin JL. Outcome after aortic valve replacement for low-flow/low-gradient aortic stenosis without contractile reserve on dobutamine stress echocardiography. J Am Coll Cardiol. 2009;53:1865–73.PubMedCrossRefGoogle Scholar
  54. 54.
    Ribeiro HB, Lerakis S, Hayek S, Gilard M, Le Ven F, Cavalcante J, Gleason T, Schindler J, Makkar R, Chakravarty T, Herrmann HC, Szeto W, Windecker S, Enriquez-Sarano M, Clavel, M. A., Cheema A, Nombela-Franco L, Jimenez-Quevedo P, Amat-Santos I, Muñio-Garcia AJ, Garcia del Blanco B, Zajarias A, Babaliaros V, Puri R, Pelletier-Beaumont E, Pibarot P, Rodés-Cabau J. Transcatheter aortic valve implantation in patients with low-flow, low-gradient aortic stenosis. The prospective multicenter topas-tavi study. Featured Clinical Research at TCT 2016. 2016.Google Scholar
  55. 55.
    Clavel MA, Messika-Zeitoun D, Pibarot P, Aggarwal S, Malouf J, Araoz P, Michelena H, Cueff C, Larose É, Capoulade R, Vahanian A, Enriquez-Sarano M. The complex nature of discordant severe calcified aortic valve disease grading: new insights from combined doppler-echocardiographic and computed tomographic study. J Am Coll Cardiol. 2013;62:2329–38.PubMedCrossRefGoogle Scholar
  56. 56.
    Pawade T, Clavel MA, Tribouilloy C, Dreyfus J, Mathieu T, Tastet L, Renard C, Gun M, Jenkins WSA, Macron L, Sechrist JW, Lacomis JM, Nguyen V, Galian Gay L, Cuellar Calabria H, Ntalas I, Cartlidge TRG, Prendergast B, Rajani R, Evangelista A, Cavalcante JL, Newby DE, Pibarot P, Messika Zeitoun D, Dweck MR. Computed tomography aortic valve calcium scoring in patients with aortic stenosis. Circ Cardiovasc Imaging. 2018;11:e007146.PubMedCrossRefGoogle Scholar
  57. 57.
    Clavel MA, Pibarot P, Messika-Zeitoun D, Capoulade R, Malouf J, Aggarval S, Araoz PA, Michelena HI, Cueff C, Larose É, Miller JD, Vahanian A, Enriquez-Sarano M. Impact of aortic valve calcification, as measured by mdct, on survival in patients with aortic stenosis: results of an International Registry Study. J Am Coll Cardiol. 2014;64:1202–13.PubMedPubMedCentralCrossRefGoogle Scholar
  58. 58.
    Tastet L, Enriquez-Sarano M, Capoulade R, Malouf J, Araoz PA, Shen M, Michelena HI, Larose É, Arsenault M, Bédard E, Pibarot P, Clavel MA. Impact of aortic valve calcification and sex on hemodynamic progression and clinical outcomes in AS. J Am Coll Cardiol. 2017;69:2096–8.PubMedCrossRefGoogle Scholar
  59. 59.
    Capoulade R, Le Ven F, Clavel MA, Dumesnil JG, Dahou A, Thébault J, Arsenault M, O'Connor K, Bédard É, Beaudoin J, Sénéchal M, Bernier M, Pibarot P. Echocardiographic predictors of outcomes in adults with aortic stenosis. Heart. 2016;102:934–42.PubMedCrossRefGoogle Scholar
  60. 60.
    Dahl JS, Eleid MF, Michelena HI, Scott CG, Suri RM, Schaff HV, Pellikka PA. Effect of left ventricular ejection fraction on postoperative outcome in patients with severe aortic stenosis undergoing aortic valve replacement. Circ Cardiovasc Imaging. 2015;8(4)Google Scholar
  61. 61.
    Généreux P, Pibarot P, Redfors B, Mack MJ, Makkar RR, Jaber WA, Svensson LG, Kapadia S, Tuzcu EM, Thourani VH, Babaliaros V, Herrmann HC, Szeto WY, Cohen DJ, Lindman BR, McAndrew T, Alu MC, Douglas PS, Hahn RT, Kodali SK, Smith CR, Miller DC, Webb JG, Leon MB. Staging classification of aortic stenosis based on the extent of cardiac damage. Eur Heart J. 2017;38:3351–8.PubMedPubMedCentralCrossRefGoogle Scholar
  62. 62.
    Magne J, Cosyns B, Popescu BA, et al. Distribution and prognostic significance of left ventricular global longitudinal strain in asymptomatic significant aortic stenosis: an individual participant data meta-analysis. JACC Cardiovasc Imaging. 2019;12:84–92.PubMedCrossRefGoogle Scholar
  63. 63.
    Clavel MA, Malouf J, Michelena HI, Suri RM, Jaffe AS, Mahoney DW, Enriquez-Sarano M. B-type natriuretic peptide clinical activation in aortic stenosis: impact on long-term survival. J Am Coll Cardiol. 2014;63:2016–25.PubMedPubMedCentralCrossRefGoogle Scholar
  64. 64.
    Chin CW, Messika-Zeitoun D, Shah AS, Lefevre G, Bailleul S, Yeung EN, Koo M, Mirsadraee S, Mathieu T, Semple SI, Mills NL, Vahanian A, Newby DE, Dweck MR. A clinical risk score of myocardial fibrosis predicts adverse outcomes in aortic stenosis. Eur Heart J. 2016;37:713–23.PubMedCrossRefGoogle Scholar
  65. 65.
    Villar AV, Garcia R, Merino D, Llano M, Cobo M, Montalvo C, Martin-Duran R, Hurle MA, Nistal JF. Myocardial and circulating levels of microRNA-21 reflect left ventricular fibrosis in aortic stenosis patients. Int J Cardiol. 2013;167:2875–81.PubMedCrossRefGoogle Scholar
  66. 66.
    Rosjo H, Dahl MB, Bye A, Andreassen J, Jorgensen M, Wisloff U, Christensen G, Edvardsen T, Omland T. Prognostic value of circulating microRNA-210 levels in patients with moderate to severe aortic stenosis. PLoS One. 2014;9:e91812.PubMedPubMedCentralCrossRefGoogle Scholar
  67. 67.
    Weidemann F, Herrmann S, Stork S, Niemann M, Frantz S, Lange V, Beer M, Gattenlohner S, Voelker W, Ertl G, Strotmann JM. Impact of myocardial fibrosis in patients with symptomatic severe aortic stenosis. Circulation. 2009;120:577–84.PubMedCrossRefGoogle Scholar
  68. 68.
    Treibel TA, López B, González A, Menacho K, Schofield RS, Ravassa S, Fontana M, White SK, DiSalvo C, Roberts N, Ashworth MT, Diez J, Moon JC. Reappraising myocardial fibrosis in severe aortic stenosis: an invasive and non-invasive study in 133 patients. Eur Heart J. 2018;39:699–709.PubMedPubMedCentralCrossRefGoogle Scholar
  69. 69.
    Everett RJ, Tastet L, Clavel MA, Chin CWL, Capoulade R, Vassiliou VS, Kwiecinski J, Gomez M, van Beek EJR, White AC, Prasad SK, Larose É, Tuck C, Semple S, Newby DE, Pibarot P, Dweck MR. Progression of hypertrophy and myocardial fibrosis in aortic stenosis: a multicenter cardiac magnetic resonance study. Circ Cardiovasc Imaging. 2018;11:e007451.PubMedPubMedCentralCrossRefGoogle Scholar
  70. 70.
    Park SJ, Cho SW, Kim SM, Ahn J, Carriere K, Jeong DS, Lee SC, Park SW, Choe YH, Park PW, Oh JK. Assessment of myocardial fibrosis using multimodality imaging in severe aortic stenosis: comparison with histologic fibrosis. JACC Cardiovasc Imaging. 2019;12(1):109–19.PubMedCrossRefGoogle Scholar
  71. 71.
    Azevedo CF, Nigri M, Higuchi ML, Pomerantzeff PM, Spina GS, Sampaio RO, Tarasoutchi F, Grinberg M, Rochitte CE. Prognostic significance of myocardial fibrosis quantification by histopathology and magnetic resonance imaging in patients with severe aortic valve disease. J Am Coll Cardiol. 2010;56:278–87.CrossRefGoogle Scholar
  72. 72.
    Dweck MR, Joshi S, Murigu T, Alpendurada F, Jabbour A, Melina G, Banya W, Gulati A, Roussin I, Raza S, Prasad NA, Wage R, Quarto C, Angeloni E, Refice S, Sheppard M, Cook SA, Kilner PJ, Pennell DJ, Newby DE, Mohiaddin RH, Pepper J, Prasad SK. Midwall fibrosis is an independent predictor of mortality in patients with aortic stenosis. J Am Coll Cardiol. 2011;58:1271–9.PubMedPubMedCentralCrossRefGoogle Scholar
  73. 73.
    Dvir D, Waksman R, Barbash IM, Kodali SK, Svensson L, Tuzcu M, Xu K, Minha S, Alu MC, Szeto WY, Thourani V, Makkar R, Kapadia S, Satler LF, Webb JG, Leon MB, Pichard AD. Outcomes of patients with chronic lung disease and severe aortic stenosis treated with transcatheter versus surgical aortic valve replacement or standard therapy: insights for the partner trial. J Am Coll Cardiol. 2014;63:269–79.PubMedCrossRefGoogle Scholar
  74. 74.
    Lindman BR, Pibarot P, Arnold SV, Suri R, McAndrew TC, Maniar HS, Zajarias A, Kodali S, Kirtane AJ, Thourani VH, Tuzcu EM, Svensson LG, Waksman R, Smith CR, Leon MB. Transcatheter versus surgical aortic valve replacement in patients with diabetes and severe aortic stenosis at high risk for surgery: an analysis of the partner trial (placement of aortic transcatheter valve). J Am Coll Cardiol. 2014;63:1090–9.PubMedCrossRefGoogle Scholar

Copyright information

© Springer Nature Switzerland AG 2020

Authors and Affiliations

  • Marie-Annick Clavel
    • 1
  • Nancy Côté
    • 1
  • Philippe Pibarot
    • 1
    Email author
  1. 1.Québec Heart & Lung Institute, Department of MedicineLaval UniversityQuébecCanada

Personalised recommendations